StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 76.68 B
Share Price
USD 159.25
Avg Daily Volume
834,388
Change (1 day)
-0.84%
Change (1 year)
-20.86%
Change (YTD)
-8.62%
CSL Limited EBT Margin for the year ending June 30, 2024: 22.97%
CSL Limited EBT Margin is 22.97% for the year ending June 30, 2024, a 13.66% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
CSL Limited EBT Margin for the year ending June 30, 2023 was 20.21%, a -23.69% change year over year.
-
CSL Limited EBT Margin for the year ending June 30, 2022 was 26.49%, a -8.23% change year over year.
-
CSL Limited EBT Margin for the year ending June 30, 2021 was 28.87%, a 2.11% change year over year.
-
CSL Limited EBT Margin for the year ending June 30, 2020 was 28.27%, a 2.76% change year over year.
Competitors
Illumina, Inc.
USD 97.44
ILMN
-1.83
-1.84%
Revvity, Inc.
USD 100.13
RVTY
-0.53
-0.53%
Syngene International Limited
USD 7.47
SYNGENE.NS
+0.09
1.17%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.17
002317.SZ
-0.07
-3.13%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.36
688321.SS
-0.02
-0.40%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Thermo Fisher Scientific Inc.
USD 419.88
TMO
-6.29
-1.48%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
RELX Plc
USD 53.46
REL.L
-0.17
-0.32%
Key Data
| Date | EBT Margin | Operating Income Margin | Gross Profit Margin | EBIT Margin |
|---|
Competitors
Illumina, Inc.
USD 97.44
ILMN
-1.83
-1.84%
Revvity, Inc.
USD 100.13
RVTY
-0.53
-0.53%
Syngene International Limited
USD 7.47
SYNGENE.NS
+0.09
1.17%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.17
002317.SZ
-0.07
-3.13%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.36
688321.SS
-0.02
-0.40%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Thermo Fisher Scientific Inc.
USD 419.88
TMO
-6.29
-1.48%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
RELX Plc
USD 53.46
REL.L
-0.17
-0.32%